The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.'s Technology in Combating Colony Collapse Disorder
WEST PALM BEACH, Fla., May 2, 2012 /PRNewswire/ -- BeesFree, Inc. (OTCBB: BEES), a company which owns patent pending technology that arrests the effects of CCD (Colony Collapse Disorder) on honeybees, announced that the Italian Experimental and Animal Prophylaxis Institute (IZS - Istituto Zooprofilattico Sperimentale) will be conducting an extensive laboratory and field project to test the effectiveness of BeesFree Inc.'s patent-pending technology.
IZS is a government agency operating within the framework of the National Health Service and has the mandate to research innovative solutions to improve animal health, welfare and food safety. IZS also provides services in the diagnosis of animal diseases, and the microbiological, chemical and physical controls over food safety, food production chains and animal feed.
BeesFree Inc. Chief Scientist and inventor of the patent-pending technology, Dr. Francesca del Vecchio, stated, "We believe this study, once completed, will confirm to beekeepers what we already know, that our proprietary chemical compound and delivery technology can effectively improve the health of honeybees and help them mitigate and avoid the effects of CCD. We greatly value our relationship with IZS and look forward to extending this cooperation agreement to cover other solutions relating to the health of honeybees."
IZS Director General, Dr. Remo Rosati stated, "IZS is proud to be associated with BeesFree and test in Italy its novel and innovative patent-pending technology to remedy CCD-related effects. We have allocated a strong team of senior chemical engineers, biologists and veterinaries for the laboratory and field test activities which will be carried out in the framework of this project. We hope this project will significantly contribute to improve our knowledge of effective solutions for honeybee health."
About BeesFree, Inc. (OTCBB:BEES)
BeesFree Inc., a company focused on developing innovative solutions for the global beekeeping community, owns a patent pending technology that helps honeybees mitigate and avoid the effects of Colony Collapse Disorder (CCD). For more information please visit www.beesfree.biz or contact the company at the numbers listed below.
Statements about the future expectations of BeesFree, Inc. and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. BeesFree, Inc. intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve certain risks and uncertainties and are subject to change at any time, Bees Free actual results could differ materially from expected results.
SOURCE BeesFree, Inc.